Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients.
Passiglia F, Galvano A, Castiglia M, Incorvaia L, Calò V, Listì A, Mazzarisi S, Perez A, Gallina G, Rizzo S, Soto Parra H, Bazan V, Russo A.
Passiglia F, et al. Among authors: castiglia m.
Ther Adv Med Oncol. 2019 Apr 16;11:1758835919839928. doi: 10.1177/1758835919839928. eCollection 2019.
Ther Adv Med Oncol. 2019.
PMID: 31019571
Free PMC article.